Functional benefit and molecular mechanism of vitamin C against perfluorooctanesulfonate-associated leukemia
Authors:
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Chemosphere
- Vol. 263, 128242
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81560134, 81660091, 81860097)
- National Natural Science Foundation of Guangxi, China (2019GXNSFBA185015, 2018GXNSFBA281025, 2018GXNSFAA281242)
This publication has 38 references indexed in Scilit:
- The molecular pathogenesis of chronic lymphocytic leukaemiaNature Reviews Cancer, 2016
- A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and immunological health conditions in humansCritical Reviews in Toxicology, 2016
- MAPK-Activated Protein Kinases (MKs): Novel Insights and ChallengesFrontiers in Cell and Developmental Biology, 2016
- The modifying effect of vitamin C on the association between perfluorinated compounds and insulin resistance in the Korean elderly: a double-blind, randomized, placebo-controlled crossover trialEuropean Journal of Nutrition, 2015
- Perfluorinated compounds: Emerging POPs with potential immunotoxicityToxicology Letters, 2014
- A critical review of perfluorooctanoate and perfluorooctanesulfonate exposure and cancer risk in humansCritical Reviews in Toxicology, 2014
- Leukemia and BenzeneInternational Journal of Environmental Research and Public Health, 2012
- Pathogenesis and treatment of leukemia: an Asian perspectiveExpert Opinion on Therapeutic Targets, 2012
- Impact of perfluorooctanesulfonate and perfluorooctanoic acid on human peripheral leukocytesToxicology in Vitro, 2011
- Formaldehyde and leukemia: Epidemiology, potential mechanisms, and implications for risk assessmentEnvironmental and Molecular Mutagenesis, 2009